Takase et al. analyzed the tissue specimens of 70 cases of esophageal squamous cell carcinoma by immunohistochemistry to investigate whether the expression level of FGF2 is related to the clinicopathological parameters of ESCC patients. Here, FGF2 is linked to esophageal squamous cell carcinoma.